術中放射治療市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、方法、應用、最終用戶、地區及競爭格局分類），2021-2031年

全球術中放射治療市場預計將從2025年的5,622萬美元成長到2031年的7,774萬美元，複合年成長率（CAGR）為5.55%。術中放射治療（IORT）是治療方法。其主要促進因素包括：能夠保護周圍健康組織，並顯著縮短治療時間，通常可以將數週的體外放射治療整合到一次手術中。這種高效性對於醫療系統滿足激增的需求至關重要。根據世界衛生組織（WHO）國際癌症研究機構（IARC）2024年的最新估計，2022年全球將新增約2,000萬例癌症病例，凸顯了全球癌症負擔的日益惡化。

然而，阻礙市場擴張的一大挑戰在於，專用放射治療設備和手術室維修（包括必要的屏蔽）需要大量的資金投入。此外，該技術還要求由外科醫生和物理學家等高技能的多學科團隊在無菌環境下密切合作，這進一步加劇了資金壁壘。這些操作上的複雜性，加上國際不同地區報銷政策的不統一，限制了許多醫療機構採用術中放射治療（IORT）技術的能力。

市場促進因素

全球癌症病例的不斷增加是推動全球術中放射線治療市場發展的主要動力，該市場對更有效率、擴充性的治療方法提出了更高的要求。不斷成長的患者群體迫使醫療系統採用能夠縮短手術等待時間和治療時長的療法，例如術中放射治療（IORT），即在一次手術中即可進行聚焦放射治療。這種需求在乳癌領域尤其突出，該領域的疾病負擔正在迅速加重。國際癌症研究機構（IARC）於2025年2月在《自然醫學》雜誌上發表的一項研究顯示，如果目前的趨勢持續下去，到2050年，全球每年新增乳癌病例將達到320萬例，這凸顯了快速開發治療技術的緊迫性。

攜帶式和小型化術中放射治療（IORT）系統的技術進步進一步推動了市場成長，因為它們無需昂貴的屏蔽手術室，並顯著降低了醫院採用這些系統的門檻。現代移動式設備能夠在標準手術室內直接進行精準的放射治療，從而提高工作流程的柔軟性和營運效率。這種向普及化技術的轉變也體現在產業領先創新者的財務表現。 Sensus Healthcare於2025年2月發布的「2024年第四季及全年財務表現」顯示，其年度營收成長71%，達到4,180萬美元，主要得益於其放射治療產品組合的成長。同時，Carl Zeiss Meditec AG於2025年12月發布的「2024/25年度報告」顯示，其總收入為22.276億歐元，凸顯了支撐這些先進解決方案的強大產業規模。

市場挑戰

安裝專用設備和維修手術室所需的高額資本投入是限制全球術中放射治療市場成長的主要障礙。醫療機構需要投入大量前期資金來安裝必要的屏蔽設施和購買先進的放射設備，這使得術中放射治療的應用主要局限於資金雄厚的大規模學術機構。由於小規模醫院往往缺乏預算來支持此類資本密集計劃，這項限制阻礙了市場滲透。此外，在無菌環境下協調一支高技能的多學科團隊的複雜操作也增加了資源壓力，進一步阻礙了潛在買家的購買意願。

報銷率下降、投資回收期延長以及採用新型放射技術的經濟可行性降低，加劇了這項財務挑戰。據美國放射腫瘤學會 (ASTRO) 稱，自 2013 年以來，根據聯邦醫療保險醫師收費標準，到 2025 年，放射腫瘤服務的支付額已下降了 25%。資金的持續減少使得醫療機構越來越難以證明術中系統所需巨額投資的合理性，從而直接阻礙了市場擴張。

市場趨勢

臨床應用拓展至神經腫瘤學和胃腸道癌症領域，顯著拓寬了全球術中放射治療市場的潛在患者群體，使其不再局限於傳統的保乳治療。醫療設備製造商正加速最佳化近距離近距離放射治療方案，以治療複雜、深部腫瘤，例如膠質母細胞瘤和腦轉移瘤。在這些病例中，精準、即時的放射治療對於預防局部復發至關重要。臨床數據也支持這項轉變。根據發表於《癌症網路》（CancerNetwork，2025年10月刊）的報告《膠原蛋白植入或可改善腦轉移瘤的局部控制》，ROADS III期臨床試驗的中期結果顯示，與標準立體定位放射治療相比，伽瑪射線片治療可將新診斷腦轉移瘤患者的腫瘤復發或死亡風險降低50%以上。

同時，機器人輔助術中放射治療的出現滿足了治療位於重要血管結構附近的惡性腫瘤時對幾何精度的迫切需求。透過將機器人定位系統與放射治療設備結合，腫瘤科醫生可以克服複雜的解剖結構限制，尤其是在腹部癌症的治療中，並在最大限度地提高放射劑量適形性的同時，保護健康組織。這種技術的協同效應有望帶來顯著的改善。根據 News-Medical.net 網站 2025 年 10 月發表的一篇報導「初步研究證實術中放射治療對胰腺癌轉移的有效性」的文章，約翰·霍普金斯大學的研究人員報告稱，利用機器人設備進行靶向術中放射治療，可有效降低局部晚期胰腺癌患者的胰週復發率至 5%。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球術中放射治療市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（術中放射治療設備、術中放射治療配件、軟體、服務）
  • 按方法（電子束、近距離放射、高劑量率放射治療、X光、其他）
  • 依應用領域（乳癌、腦瘤、頭頸癌、軟組織肉瘤、兒童腫瘤、婦科癌症、泌尿生殖系統癌症、其他）
  • 按最終使用者（醫院/診所、門診護理中心、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美術中放射治療市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲術中放射治療市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區術中放射治療市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲術中放射治療市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美術中放射治療市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球術中放射治療市場：SWOT分析

第14章 波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• IntraOp Medical, Inc
• iCAD, Inc.
• Elekta AB
• Sensus Healthcare, Inc.
• Isoray, Inc.
• Becton, Dickinson and Company
• Sordina IORT Technologies
• Varian Medical Systems, Inc.
• SeeDos Ltd.
• IsoAid LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Intraoperative Radiation Therapy Market is projected to grow from USD 56.22 Million in 2025 to USD 77.74 Million by 2031, achieving a CAGR of 5.55%. Intraoperative Radiation Therapy (IORT) involves delivering a concentrated dose of radiation directly to the tumor bed during surgery, immediately following the resection of the malignancy. Primary drivers include the clinical ability to preserve healthy surrounding tissue and the significant reduction of treatment duration, often converting weeks of external therapy into a single operative session. This efficiency is critical as healthcare systems manage escalating demand; according to the World Health Organization's International Agency for Research on Cancer, updated 2024 estimates highlighted the growing global burden with approximately 20 million new cancer cases recorded in 2022.

However, a significant challenge hindering market expansion is the high capital investment required for acquiring specialized radiation equipment and retrofitting operating rooms with necessary shielding. This financial barrier is further compounded by the stringent requirement for highly skilled multidisciplinary teams, including surgeons and physicists, to coordinate precisely within a sterile environment. These operational complexities, combined with inconsistent reimbursement policies in various international regions, limit the capacity of many healthcare facilities to adopt IORT technologies.

Market Driver

The escalating global prevalence of cancer cases acts as a primary catalyst for the Global Intraoperative Radiation Therapy Market, necessitating more efficient and scalable treatment modalities. As patient volumes rise, healthcare systems are compelled to adopt therapies that reduce surgical backlogs and treatment duration, such as IORT, which delivers concentrated radiation in a single operative session. This demand is particularly acute in breast oncology, where the burden is expanding rapidly; according to the International Agency for Research on Cancer, a study published in 'Nature Medicine' in February 2025 projected that by 2050, the annual global incidence will reach 3.2 million new breast cancer cases if current trends persist, underscoring the urgent necessity for expedited therapeutic techniques.

Technological advancements in portable and miniaturized IORT systems further propel market growth by eliminating the need for expensive, shielded operating bunkers, thereby lowering substantial adoption barriers for hospitals. Modern mobile units allow for precise radiation delivery directly in standard operating rooms, enhancing workflow versatility and operational efficiency. This shift towards accessible technology is reflected in the financial performance of key industry innovators; according to Sensus Healthcare's 'Fourth Quarter and Full Year 2024 Financial Results' from February 2025, the company reported a 71% increase in full-year revenue to $41.8 million driven by its radiation therapy portfolio, while Carl Zeiss Meditec AG's 'Annual Report 2024/25' from December 2025 showed a total revenue of €2,227.6 million, highlighting the robust industrial scale supporting these advanced solutions.

Market Challenge

The substantial capital expenditure required for acquiring specialized equipment and retrofitting operating rooms stands as a formidable barrier to the growth of the Global Intraoperative Radiation Therapy Market. Healthcare facilities face significant upfront costs to install necessary shielding and procure high-tech radiation devices, which limits adoption primarily to large, well-funded academic centers. This restriction prevents widespread market penetration, as smaller hospitals often lack the budget to support such capital-intensive projects. Additionally, the operational complexity of coordinating highly skilled multidisciplinary teams within sterile environments adds to the resource burden, further deterring potential buyers.

This financial challenge is critically aggravated by declining reimbursement rates, which extend the return on investment period and reduce the economic viability of adopting new radiation technologies. According to the American Society for Radiation Oncology in 2025, payment reductions for radiation oncology services under the Medicare Physician Fee Schedule have reached 25% since 2013. Such consistent decreases in financial support make it increasingly difficult for healthcare providers to justify the heavy investment needed for intraoperative systems, thereby directly stifling market expansion.

Market Trends

The expansion of clinical applications to neuro-oncology and gastrointestinal cancers is significantly broadening the addressable patient base for the Global Intraoperative Radiation Therapy Market beyond its traditional stronghold in breast conservation. Medical device manufacturers are increasingly tailoring brachytherapy solutions to treat complex, deep-seated tumors such as glioblastomas and brain metastases, where precise, immediate radiation is crucial to prevent local failure. This shift is supported by clinical data; according to the 'Collagen Implant May Improve Local Control of Metastatic Brain Tumors' report in CancerNetwork (October 2025), interim findings from the Phase 3 ROADS trial indicated that GammaTile therapy reduced the risk of tumor recurrence or death by more than 50% compared to standard stereotactic radiotherapy in patients with newly diagnosed brain metastases.

Simultaneously, the emergence of robotic-assisted intraoperative radiation delivery is addressing the critical need for geometric precision when treating malignancies located near vital vascular structures. The integration of robotic positioning systems with radiation delivery devices allows oncologists to navigate difficult anatomical constraints, particularly in abdominal cancers, maximizing dose conformity while sparing healthy tissue. This technological synergy is demonstrating remarkable improvements; according to the 'Preliminary study shows intraoperative radiation's success against pancreatic cancer spread' article on News-Medical.net (October 2025), investigators at Johns Hopkins reported that utilizing a robotic device for targeted intraoperative radiation effectively reduced the recurrence rate around the pancreas to just 5% in patients with locally advanced pancreatic cancer.

Key Market Players

• IntraOp Medical, Inc
• iCAD, Inc.
• Elekta AB
• Sensus Healthcare, Inc.
• Isoray, Inc.
• Becton, Dickinson and Company
• Sordina IORT Technologies
• Varian Medical Systems, Inc.
• SeeDos Ltd.
• IsoAid LLC

Report Scope

In this report, the Global Intraoperative Radiation Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intraoperative Radiation Therapy Market, By Product

• Intraoperative Radiation Therapy Devices
• Intraoperative Radiation Therapy Accessories
• Software
• Services

Intraoperative Radiation Therapy Market, By Method

• Electron
• Intraoperative Brachytherapy
• High Dose-Rate
• X-Ray
• Others

Intraoperative Radiation Therapy Market, By Application

• Breast Cancer
• Brain Tumor
• Head and Neck Cancer
• Soft Tissue Sarcoma
• Pediatric Tumors
• Gynecological Cancer
• Genitourinary Cancers
• Others

Intraoperative Radiation Therapy Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Intraoperative Radiation Therapy Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intraoperative Radiation Therapy Market.

Available Customizations:

Global Intraoperative Radiation Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intraoperative Radiation Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Intraoperative Radiation Therapy Devices, Intraoperative Radiation Therapy Accessories, Software, Services)
  • 5.2.2. By Method (Electron, Intraoperative Brachytherapy, High Dose-Rate, X-Ray, Others)
  • 5.2.3. By Application (Breast Cancer, Brain Tumor, Head and Neck Cancer, Soft Tissue Sarcoma, Pediatric Tumors, Gynecological Cancer, Genitourinary Cancers, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Intraoperative Radiation Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Method
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intraoperative Radiation Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Method
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Intraoperative Radiation Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Method
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Intraoperative Radiation Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Method
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Intraoperative Radiation Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Method
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Intraoperative Radiation Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Method
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Intraoperative Radiation Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Method
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Intraoperative Radiation Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Method
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Intraoperative Radiation Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Method
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Intraoperative Radiation Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Method
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Intraoperative Radiation Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Method
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Intraoperative Radiation Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Method
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Intraoperative Radiation Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Method
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Intraoperative Radiation Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Method
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Intraoperative Radiation Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Method
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Intraoperative Radiation Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Method
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Intraoperative Radiation Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Method
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Intraoperative Radiation Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Method
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Intraoperative Radiation Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Method
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Intraoperative Radiation Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Method
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Intraoperative Radiation Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Method
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Intraoperative Radiation Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Method
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Intraoperative Radiation Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Method
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Intraoperative Radiation Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Method
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Intraoperative Radiation Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. IntraOp Medical, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. iCAD, Inc.
• 15.3. Elekta AB
• 15.4. Sensus Healthcare, Inc.
• 15.5. Isoray, Inc.
• 15.6. Becton, Dickinson and Company
• 15.7. Sordina IORT Technologies
• 15.8. Varian Medical Systems, Inc.
• 15.9. SeeDos Ltd.
• 15.10. IsoAid LLC

16. Strategic Recommendations

17. About Us & Disclaimer